TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NBP

NovaBridge Biosciences

Healthcare · Biotechnology

1.40$ -1.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

NovaBridge Biosciences (NBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NBP
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
11 54 30 1,543 88 -11 4.5 0.0 0.0
– – – – 46 27 0.0 – 0.9
12 54 30 1,543 42 -11 4.5 – -0.9
267 426 840 985 190 156 114 159 9.0
25 66 655 402 900 200 64 216 4.5
293 492 1,495 1,387 2,113 355 516 375 13
-274 -456 -1,465 156 -2,071 -366 -511 -375 -13
0.9 1.7 0.4 0.1 0.0 0.0 0.1 – –
-291 -417 -1,452 483 -2,332 -973 -1,466 -363 -13
– 1.7 – 12 -0.5 -5.6 -1,259 – –
-298 -403 -1,448 471 -2,332 -968 -1,466 -162 -6.6
-279 -432 -197 168 -2,058 -356 -344 -373 -13

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?